Accu-Chek SmartGuide
-
• Our ambition: Making SmartGuide the #2 CGM in LATAM with a patient share of +20% in 2028.
• 2026 sales target: 6 million CHF and a patient share of 7.4%
Take a look at what’s coming in 2026!
-
What is it?
• A clinical study evaluating the impact of glucose prediction features on clinical outcomes in people using Accu-Chek SmartGuide, comparing cohorts with and without access to prediction.
Why is it important?
• There is limited clinical evidence demonstrating the impact of prediction features on patient outcomes, which is critical for s here healthcare professionals’ confidence and adoption of the technology.
Key benefits
• Generate real-world clinical evidence to support clinical adoption.
• Enable stronger scientific discussions with healthcare professionals.
• Support value-based conversations with payers.
• Differentiate our solution from Abbott!
When is it happening?
• Study kickoff: Q2 2026
• End of patients inclusion: Q4 2026
• Publication: Q1 2027 -
What is it?
• A partnership with an external, well-established educational platform to scale medical education on prediction and SmartGuide.
Why is it important?
• Predictive glucose management represents a new care paradigm, and without education, its differentiation versus established CGM competitors is lost, limiting clinical adoption. With Medscape, we can reach more than 15,000 endocrinolgists and diabetologists, an audience we can’t reach with our current internal team.
Key benefits
• Build clinical confidence in SmartGuide and its predictive value.
• Support the transition from reactive to proactive diabetes care.
• Accelerate appropriate clinical adoption across broader HCP audiences.
When is it happening?
• The campaign is already available for endocrinolgists and diabetologists across LATAM!
Check it out at https://predictiveacademy.medscapegroup.com/ -
What is it?
• A digital patient portal designed to educate and support people using SmartGuide, with a specific focus on understanding and applying glucose prediction insights to daily decision-making.
Why is it important?
• Prediction is the key differentiating feature of SmartGuide, yet patients and healthcare professionals often lack sufficient education on how to interpret and act on predictive insights. Without this, perceived value, correct use, and long-term engagement with the sensor are compromised.
Key benefits
• Enable proper understanding and use of prediction features.
• Increase perceived value, engagement, and long-term retention with SmartGuide.
• Support healthcare professionals in translating prediction insights into practical clinical guidance.
When is it happening?
• This project is under development. First deliverables are expected by Q2 2026. Stay tuned! -
What it is?
• A regional ambassador program powered by Roche that brings together five influential content creators living with diabetes. This community is the starting point of a movement that blends science, empathy, and action, supported by a network of strategic allies, including medical experts, activists, and Roche spokespeople.
Why it is important?
• In a world driven by data, stories are what truly connect. This program is vital because it humanizes technology. It demonstrates how SmartGuide’s predictive capabilities translate into real-life benefits, transforming clinical innovation into a powerful movement that advocates for a more proactive and confident lifestyle for the diabetes community in Latin America.
Key Benefits
• Authentic Inspiration: Real-life stories that show how predicting glucose trends leads to daily peace of mind and well-being.
• Expert Backing: A unique collaboration between patient voices and scientific experts to provide reliable, high-quality information.
• A Growing Community: Access to a regional movement dedicated to breaking barriers and fostering a "predictive mindset" in diabetes management.
• Science with Empathy: A platform where technology meets the human experience to prove that anticipating the future is the ultimate form of care.
When is it happening?
H2 2026. Stay alert! -
What it is?
• The toolkit is a manual that summarizes, for each stage of the sales funnel, the key messages that should be conveyed during each medical visit cycle. It also suggests an implementation plan for these cycles based on the physician's classification. It will be a fundamental resource for sales force training, as it includes a suggested script and identifies the critical factors for a successful visit.
• Success in a medical visit is not just about what you say, but when and to whom you say it It ensures that every member of the sales force, regardless of territory, delivers a unified brand story.
Key Benefits
• Ensures the strategic key messages are delivered consistently across the entire sales force, minimizing message dilution from the first visit to the last.
• Helps the sales force prioritize high-impact interactions, ensuring the most valuable information is conveyed at the right stage of the sales funnel.
When is it happening?
• It’s already live, and the affiliates have been trained by the CoE team! Click here if you want to know more about this campaign! -
Behind every statistic, there's a story of peace of mind.
The true measure of SmartGuide's success lies not in its algorithms but in the daily lives of its users. In this section, we share the testimonials of patients who have transformed uncertainty into security, allowing continuous prediction to become their greatest ally for living without surprises and with complete control over their well-being. Meet the patients and their stories:
Story 1
Story 2
Story 3